rian.ie - Results

A A A

Current Search:	'biology' in all fields;

Displaying Results 201 - 225 of 1817 on page 9 of 73

Mark

Teacher Design Teams (TDTs) - building capacity for innovation, learning and curriculum implementation in the continuing professional development of in-career teachers (2007)

Mooney Simmie, Geraldine

Mark

Potential of Vibrational Spectroscopy in the Diagnosis of Human Tumours. (2006)

O'Faolain, Eoghan

Mark

Tinman Regulates NetrinB in the Cardioblasts of the Drosophila Dorsal Vessel. (2016)

LABRADOR, JUAN

Mark

Applying quantitative methods to conservation planning : Population dynamics of the Eurasian otter in Ireland (2008)

? N?ill, Lughaidh

Mark

The role of Notch1 Receptor N-glycosylation in the transition of stem cells to vascular smooth muscle cells (2018)

Olayinka, Abidemi

Mark

Young people's perspectives on genetics, identity and society using film and discussion (2005)

Murphy, Padraig

Mark

Biomarkers for Placental Abnormality (2005)

McCarthy, Cathal

Mark

Release of HMGB1 in Response to Pro-Apoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity (2010)

Candolfi, Marianela; Yagiz, Kader; Foulad, David; Alzadeh, Gabrielle; Tesarfreund, Matt...

Release of HMGB1 in Response to Pro-Apoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity (2010)

Candolfi, Marianela; Yagiz, Kader; Foulad, David; Alzadeh, Gabrielle; Tesarfreund, Matthew; Muhammad, AKM Ghulam; Puntel, Mariana; Kroeger, Kurt; Liu, Chunyan; Lee, Sharon; Curtin, James; King, Gwendalyn D; Lerner, Jonathan; Sato, Katsuaki; Mineharu, Yohei; Xiong, Weidong; Lowenstein, Pedro R; Castro, Maria

Abstract:

Purpose In preparation for a Phase I clinical trial utilizing a combined cytotoxic/immunotherapeutic strategy using adenoviruses expressing Flt3L (Ad-Flt3L) and thymidine kinase (Ad-TK) to treat glioblastoma (GBM), we tested the hypothesis that Ad-TK+GCV would be the optimal tumor killing agent in relation to efficacy and safety when compared to other pro-apoptotic approaches. Experimental Design and Results The efficacy and neurotoxicity of Ad-TK+GCV was compared with Ads encoding the pro-apoptotic cytokines (TNF-α, TRAIL, FasL), alone or in combination with Ad-Flt3L. In rats bearing small GBMs (day 4), only Ad-TK+GCV or Ad-FasL improved survival. In rats bearing large GBMs (day 9), the combination of Ad-Flt3L with Ad-FasL did not improve survival over FasL alone, while Ad-Flt3L combined with Ad-TK+GCV led to 70% long-term survival. Expression of FasL and TRAIL caused severe neuropathology, which was not encountered when we utilized Ad-TK+/−Ad-Flt3L. In vitro, all treatments elicit...